HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bone-targeted Src kinase inhibitors: novel pyrrolo- and pyrazolopyrimidine analogues.

Abstract
Src tyrosine kinase is a therapeutic target for bone diseases that has been validated by gene knockout studies. Furthermore, in vitro cellular studies implicate that Src has a positive regulatory role in osteoclasts and a negative regulatory role in osteoblasts. The potential use of Src inhibitors for osteoporosis therapy has been previously shown by novel bone-targeted ligands of the Src SH2 (e.g., AP22408) and non-bone-targeted, ATP-based inhibitors of Src kinase. Significant to this study, compounds 2-12 exemplify novel analogues of known pyrrolopyrimidine and pyrazolopyrimidine template-based Src kinase inhibitors that incorporate bone-targeting group modifications designed to provide tissue (bone) selectivity and diminished side effects. Accordingly, we report here the structure-based design, synthetic chemistry and biological testing of these compounds and proof-of-concept studies thereof.
AuthorsRaji Sundaramoorthi, William C Shakespeare, Terence P Keenan, Chester A Metcalf 3rd, Yihan Wang, Ukti Mani, Merry Taylor, Shuangying Liu, Regine S Bohacek, Surinder S Narula, David C Dalgarno, Marie Rose van Schravandijk, Sheila M Violette, Shuenn Liou, Susan Adams, Mary K Ram, Jeffrey A Keats, Manfred Weigle, Tomi K Sawyer, Manfred Weigele
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 13 Issue 18 Pg. 3063-6 (Sep 15 2003) ISSN: 0960-894X [Print] England
PMID12941334 (Publication Type: Journal Article)
Chemical References
  • Enzyme Inhibitors
  • Purines
  • Pyrimidines
  • Adenosine Triphosphate
  • src-Family Kinases
Topics
  • Adenosine Triphosphate (analogs & derivatives)
  • Animals
  • Bone Diseases (drug therapy)
  • Drug Design
  • Enzyme Inhibitors (chemical synthesis, pharmacology)
  • Humans
  • Inhibitory Concentration 50
  • Models, Molecular
  • Osteoporosis (drug therapy)
  • Purines (chemical synthesis, pharmacology)
  • Pyrimidines (chemical synthesis, pharmacology)
  • Structure-Activity Relationship
  • src-Family Kinases (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: